Chapter 4
Specialized Pro-Resolving Lipid Derived Fatty Acid Mediators: Wiring the Circuitry of Effector Immune Homeostasis
Gabrielle Fredman,
Charles N. Serhan,
Gabrielle Fredman
Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Search for more papers by this authorCharles N. Serhan
Search for more papers by this authorGabrielle Fredman,
Charles N. Serhan,
Gabrielle Fredman
Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Search for more papers by this authorCharles N. Serhan
Search for more papers by this authorBook Editor(s):Hannu Larjava,
Hannu Larjava
Search for more papers by this authorFirst published: 13 April 2012
Summary
This chapter contains sections titled:
-
Inflammation: The Cardinal Signs
-
Complete Resolution and Tissue Homeostasis is the Ideal Outcome of Acute Inflammation
-
Lipoxins, Resolvins, Protectins and Maresins: Semper Vigilantes of Anti-Inflammation and Pro-Resolution
-
Resolution of Inflammation is an Actively Regulated Process in Vivo
-
Resolvins and Protectins are Protective in Experimental Models of Inflammatory Diseases
-
Specialized Pro-Resolving Lipid Mediators in Oral Medicine: Restoration of Tissue Homeostasis in Experimental Periodontitis
-
Resolution and Wound Healing
-
Anti-Inflammation vs. Pro-Resolution
-
Clinical Implications and the Development of Stable Analogs
-
Conclusions
-
Acknowledgments
-
References
REFERENCES
- Abramson, S., Edelson, H., Kaplan, H., Given, W., Weissmann, G. (1983) The neutrophil in rheumatoid arthritis: its role and the inhibition of its activation by nonsteroidal antiinflammatory drugs. Seminars in Arthritis and Rheumatism, 13, 148–53.
- Ariel, A., Li, P.L., Wang, W., et al. (2005) The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem, 280, 43079–86.
- Arita, M., Bianchini, F., Aliberti, J., et al. (2005a) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. Journal of Experimental Medicine, 201, 713–22.
- Arita, M., Yoshida, M., Hong, S., et al. (2005b) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proceedings of the National Academy of Sciences USA, 102, 7671–6.
- Bandeira-Melo, C., Serra, M.F., Diaz, B.L., et al. (2000) Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol, 164, 1029–36.
- Bannenberg, G.L. (2009) Resolvins: current understanding and future potential in the control of inflammation. Current Opinion in Drug Discovery and Development, 12, 644–58.
- Bannenberg, G., Moussignac, R.L., Gronert, K., et al. (2004) Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. British Journal of Pharmacology, 143, 43–52.
- Bannenberg, G.L., Chiang, N., Ariel, A., et al. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. Journal of Immunology, 174, 4345–55.
- Bazan, N.G., Gordon, W.C., Rodriguez de Turco, E.B. (1992) Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. Advances in Experimental Medicine and Biology, 318, 295–306.
- Bergstroem, S., Danielsson, H., Samuelsson, B. (1964) The enzymatic formation of prostaglandin E2 from arachidonic acid prostaglandins and related factors 32. Biochim Biophysica Acta, 90, 207–10.
- Birnbaum, Y., Ye, Y., Lin, Y., et al. (2006) Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation, 114, 929–35.
- Blumberg, R.S., Strober, W. (2001) Prospects for research in inflammatory bowel disease. JAMA, 285, 643–7.
- Borgeat, P., Samuelsson, B. (1979a) Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A 23187. Proceedings of the National Academy of Sciences USA, 76, 2148–52.
- Borgeat, P., Samuelsson, B. (1979b) Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes Formation of a novel dihydroxyeicosatetraenoic acid. Journal of Biological Chemistry, 254, 2643–6.
- Campbell, E.L., Louis, N.A., Tomassetti, S.E., et al. (2007) Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB Journal, 21, 3162–70.
- Canny, G., Levy, O., Furuta, G.T., et al. (2002) Lipid mediator-induced expression of bactericidal/ permeability- increasing protein (BPI) in human mucosal epithelia. Proceedings of the National Academy of Sciences USA, 99, 3902–7.
- Chiang, N., Bermudez, E.A., Ridker, P.M., Hurwitz, S., Serhan, C.N. (2004) Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proceedings of the National Academy of Sciences USA, 101, 15178–83.
- Chiang, N., Gronert, K., Clish, C.B., O'Brien, J.A., Freeman, M.W., Serhan, C.N. (1999) Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest, 104, 309–316.
- Chiang, N., Schwab, J.M., Fredman, G., Kasuga, K., Gelman, S., Serhan, C.N. (2008) Anesthetics impact the resolution of inflammation. PLoS ONE, 3, e 1879.
- Claria, J., Serhan, C.N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proceedings of the National Academy of Sciences USA, 92, 9475–9.
- Clish, C.B., O'Brien, J.A., Gronert, K., Stahl, G.L., Petasis, N.A., Serhan, C.N. (1999) Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad SciUSA, 96, 8247–52.
- Connor, K.M., Sangiovanni, J.P., Lofqvist, C., et al. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nature Medicine, 13, 868–73.
- Dangi, B., Obeng, M., Nauroth, J.M., et al. (2009) Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6). Journal of Biological Chemistry, 284, 14744–59.
- Devchand, P.R., Schmidt, B.A., Primo, V.C., et al. (2005) A synthetic eicosanoid LX-mimetic unravels host–donor interactions in allogeneic BMT-induced GvHD to reveal an early protective role for host neutrophils. FASEB J, 19, 203–210.
- Drucker, M., Cardenas, E., Arizti, P., Valenzuela, A., Gamboa, A. (1998) Experimental studies on the effect of lidocaine on wound healing. World Journal of Surgery, 22, 394–7; discussion 397–8.
- Duffield, J.S., Hong, S., Vaidya, V.S., et al. (2006) Resolvin D series and protectin D1 mitigate acute kidney injury. Journal of Immunology, 177, 5902–11.
- Fierro, I.M., Kutok, J.L., Serhan, C.N. (2002) Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). J Pharmacol Exp Ther, 300, 385–92.
- Gewirtz, A.T., Neish, A.S., Madara, J.L. (2002) Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins. Adv Exper Med Biol, 507, 229–36.
- Gilroy, D.W., Colville-Nash, P.R., Willis, D., Chivers, J., Paul-Clark, M.J., Willoughby, D. A. (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nature Medicine, 5, 698–701.
- Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., Brady, H.R. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. Journal of Immunology, 164, 1663–7.
- Gonzalez-Periz, A., Horrillo, R., Ferre, N., et al. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins. FASEB J, 23, 1946–57.
- Gronert, K. (2005) Lipoxins in the eye and their role in wound healing. Prostaglandins, Leukotrienes and Essential Fatty Acids, 73, 221–9.
- Gronert, K., Maheshwari, N., Khan, N., Hassan, I.R., Dunn, M., Laniado Schwartzman, M. (2005) A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. Journal of Biological Chemistry, 280, 15267–78.
- Hasturk, H., Kantarci, A., Ohira, T., et al. (2006) RvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis. FASEB Journal, 20, 401–403.
- Hasturk, H., Kantarci, A., Goguet-Surmenian, E., et al. (2007) Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. Journal of Immunology, 179, 7021–9.
- Haworth, O., Cernadas, M., Yang, R., Serhan, C.N., Levy, B.D. (2008) Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nature Immunology, 9, 873–9.
- Hong, S., Gronert, K., Devchand, P.R., Moussignac, R.L., Serhan, C.N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells Autacoids in anti-inflammation. Journal of Biological Chemistry, 278, 14677–87.
- Hudert, C.A., Weylandt, K.H., Lu, Y., et al. (2006) Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proceedings of the National Academy of Sciences USA, 103, 11276–81.
- Kang, J.X., Wang, J., Wu, L., Kang, Z.B. (2004) Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature, 427, 504.
- Karp, C.L., Flick, L.M., Park, K.W., et al. (2004) Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol, 5, 388–92.
- Kieran, N.E., Doran, P.P., Connolly, S.B., et al. (2003) Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney International, 64, 480–92.
- Kumar, V., Abbas, A.K., Fausto, N., Robbins, S.L., Cotran, R.S. (2005) Robbins and Cotran Pathologic Basis of Disease. Philadelphia, Elsevier/Saunders.
- Lee, H.T., Krichevsky, I.E., Xu, H., Ota-Setlik, A., D'agati, V.D., Emala, C.W. (2004) Local anesthetics worsen renal function after ischemia-reperfusion injury in rats. American Journal of Physiology . Renal Physiology, 286, F111–19.
- Leonard, M.O., Hannan, K., Burne, M.J., et al. (2002) 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. Journal of the American Society of Nephrology, 13, 1657–62.
- Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K., Serhan, C.N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunology, 2, 612–19.
- Levy, B.D., De Sanctis, G.T., Devchand, P.R., et al. (2002) Multi-pronged inhibition of airway hyperresponsiveness and inflammation by lipoxin A(4). Nat Med, 8, 1018–23.
- Levy, B.D., Kohli, P., Gotlinger, K., et al. (2007a) Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol, 178, 496–502.
- Levy, O., Canny, G., Serhan, C.N., Colgan, S.P. (2003) Expression of BPI (bactericidal/permeabilityincreasing protein) in human mucosal epithelia. Biochemical Society Transactions, 31, 795–800.
- Libby, P., Ridker, P.M., Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 1135–43.
- Lukiw, W.J., Bazan, N.G. (2008) Docosahexaenoic acid and the aging brain. J Nutr, 138, 2510–14.
- Maddox, J.F., Serhan, C.N. (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. Journal of Experimental Medicine, 183, 137–46.
- Maddox, J.F., Hachicha, M., Takano, T., Petasis, N.A., Fokin, V.V., Serhan, C.N. (1997) Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. Journal of Biological Chemistry, 272, 6972–8.
- Majno, G. (1991) The Healing Hand: Man and Wound in the Ancient World. Cambridge, Massachusetts, Harvard University Press.
- Majno, G., Joris, I. (2004) Cells, Tissues, and Disease: Principles of General Pathology. New York, Oxford University Press.
- Marcheselli, V.L., Hong, S., Lukiw, W.J., et al. (2003) Novel docosanoids inhibit brain ischemiareperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. Journal of Biological Chemistry, 278, 43807–17.
- Mitchell, S., Thomas, G., Harvey, K., et al. (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. Journal of the American Society of Nephrology, 13, 2497–507.
- Mukherjee, P.K., Marcheselli, V.L., Serhan, C.N., Bazan, N.G. (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proceedings of the National Academy of Sciences USA, 101, 8491–6.
- O'Sullivan, T.P., Vallin, K.S., Shah, S.T., et al. (2007) Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities. Journal of Medicinal Chemistry, 50, 5894–902.
- Papayianni, A., Serhan, C.N., Phillips, M.L., Rennke, H.G., Brady, H.R. (1995) Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney Int, 47, 1295–302.
- Petasis, N.A., Keledjian, R., Sun, Y.P., et al. (2008) Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties. Bioorganic and Medicinal Chemistry Letters, 18, 1382–7.
- Qiu, F.H., Devchand, P.R., Wada, K., Serhan, C.N. (2001) Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB Journal, 15, 2736–8.
- Rowley, A.F., Lloyd-Evans, P., Barrow, S.E., Serhan, C.N. (1994) Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. Biochemistry, 33, 856–63.
- Ryan, G.B., Majno, G. (1977) Acute inflammation. A review. American Journal of Pathology, 86, 183–276.
- Samuelsson, B. (1979) Prostaglandins, thromboxanes, and leukotrienes: formation and biological roles. Harvey Lecture, 75, 1–40.
- Samuelsson, B. (1983). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science, 220, 568–75.
- Samuelsson, B., Dahlen, S.E., Lindgren, J.A., Rouzer, C.A., Serhan, C.N. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science, 237, 1171–6.
- Sangiovanni, J.P., Chew, E.Y. (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in Retinal and Eye Research, 24, 87–138.
- Scalia, R., Gefen, J., Petasis, N.A., Serhan, C.N., Lefer, A.M. (1997) Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci USA, 94, 9967–72.
- Schwab, J.M., Chiang, N., Arita, M., Serhan, C.N. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature, 447, 869–74.
- Serhan, C.N. (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annual Review of Immunology, 25, 101–37.
- Serhan, C.N., Chiang, N. (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. British Journal of Pharmacology, 153 (Suppl 1), S200–215.
- Serhan, C.N., Drazen, J.M. (1997) Antiinflammatory potential of lipoxygenase-derived eicosanoids: a molecular switch at 5 and 15 positions? Journal of Clinical Investigation, 99, 1147–8.
- Serhan, C.N., Guest Ed. (2005) Special issue on lipoxins and aspirin-triggered lipoxins. Prostaglandins, Leukotrienes and Essential Fatty Acids, 73(3–4), 139–321.
- Serhan, C.N., Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nature Immunology, 6, 1191–7.
- Serhan, C.N., Maddox, J.F., Petasis, N.A., et al. (1995) Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry, 34, 14609–15.
- Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N., Gronert, K. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. Journal of Experimental Medicine, 192, 1197–204.
- Serhan, C.N., Hong, S., Gronert, K., et al. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. Journal of Experimental Medicine, 196, 1025–37.
- Serhan, C.N., Jain, A., Marleau, S., et al. (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. Journal of Immunology, 171, 6856–65.
- Serhan, C.N., Jain, A., Marleau, S., et al. (2003a) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol, 171, 6856–65.
- Serhan, C.N., Arita, M., Hong, S., Gotlinger, K. (2004a) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids, 39, 1125–32.
- Serhan, C.N., Gotlinger, K., Hong, S., Arita, M. (2004b) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediators, 73, 155–72.
- Serhan, C.N., Gotlinger, K., Hong, S., et al. (2006) Anti-inflammatory actions of neuroprotectin D1/ protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. Journal of Immunology, 176, 1848–59.
- Serhan, C.N., Brain, S.D., Buckley, C.D., et al. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB Journal, 21, 325–32.
- Serhan, C.N., Chiang, N., Van Dyke, T.E. (2008a) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Review Immunology, 8, 349–61.
- Serhan, C.N., Yacoubian, S., Yang, R. (2008b) Anti-inflammatory and proresolving lipid mediators. Annual Review of Pathology, 3, 279–312.
- Serhan, C.N., Yang, R., Martinod, K., et al. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. Journal of Experimental Medicine, 206, 15–23.
- Sheets, K.G., Elison, Z.Y. Jr, Gjörstrup, P., Gordon, W.C., Bergsma, D.R., Bazan, N.G. (2009) An analog of resolvin E1 inhibits endothelial cell growth in retina following laser-induced choroidal neovascularization (CNV). In: Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale, Florida, USA.
- Spite, M., Norling, L.V., Summers, L., et al. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature, 461, 1287–91.
- Sun, Y.P., Oh, S.F., Uddin, J., et al. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. Journal of Biology and Chemistry, 282, 9323–34.
- Svensson, C.I., Zattoni, M., Serhan, C.N. (2007) Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J Exp Med, 204, 245–52.
- Takano, T., Clish, C.B., Gronert, K., Petasis, N., Serhan, C.N. (1998) Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. Journal of Clinical Investigation, 101, 819–26.
-
Tauber, A.I., Chernyak, L. (1991) Metchnikoff and the Origins of Immunology: From Metaphor to Theory. Oxford, Oxford University Press.
10.1093/oso/9780195064476.001.0001 Google Scholar
- Tjonahen, E., Oh, S.F., Siegelman, J., et al. (2006) Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chemistry and Biology, 13, 1193–202.
- Van Dyke, T.E. (2007) Control of inflammation and periodontitis. Periodontol 2000, 45, 158–66.
- Van Dyke, T.E. (2008) The management of inflammation in periodontal disease. Journal of Periodontology, 79, 1601–8.
- Van Dyke, T.E., Serhan, C.N. (2006) A novel approach to resolving inflammation. Scientific American Oral and Whole Body Health, 2006, 42–45.
- Vane, J.R. (1976) The mode of action of aspirin and similar compounds. Journal of Allergy and Clinical Immunology, 58, 691–712.
